9-136742828-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000497771.6(LCN10):c.76G>A(p.Glu26Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000497771.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCN10 | NM_001001712.3 | c.76G>A | p.Glu26Lys | missense_variant | 1/6 | ENST00000497771.6 | NP_001001712.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCN10 | ENST00000497771.6 | c.76G>A | p.Glu26Lys | missense_variant | 1/6 | 1 | NM_001001712.3 | ENSP00000418491.1 | ||
ENSG00000204003 | ENST00000435202.5 | n.*183G>A | non_coding_transcript_exon_variant | 7/11 | 2 | ENSP00000399627.1 | ||||
ENSG00000204003 | ENST00000435202.5 | n.*183G>A | 3_prime_UTR_variant | 7/11 | 2 | ENSP00000399627.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461318Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727000
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2022 | The c.76G>A (p.E26K) alteration is located in exon 1 (coding exon 1) of the LCN10 gene. This alteration results from a G to A substitution at nucleotide position 76, causing the glutamic acid (E) at amino acid position 26 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at